Halt-RONIN will develop novel models that can be used to advance the understanding of NAFL-to-NASH progression, the discovery of novel biomarkers and the development of targeted and (cost-) effective drugs against the disease.

Optimizing processes

A better understanding of the disease progression and risk factors will lead to the reduction of healthcare costs and shorter treatment times by enabling a faster drug development, facilitating the development of personalized treatment options and finally limiting the prevalence of NAFL/NASH.